[
  {
    "ts": null,
    "headline": "Top 15 High-Growth Dividend Stocks For June 2025",
    "summary": "Discover my June 2025 Top 15 high-growth dividend stocks, offering a 1.34% yield, 22.82% growth rate, and 25% undervaluation.",
    "url": "https://finnhub.io/api/news?id=ed68f4a9a8b1fc6054e82029468c3ffe75e2075c44a02f5a1258d00dc3214a7c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748858400,
      "headline": "Top 15 High-Growth Dividend Stocks For June 2025",
      "id": 134939275,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1921790815/image_1921790815.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "Discover my June 2025 Top 15 high-growth dividend stocks, offering a 1.34% yield, 22.82% growth rate, and 25% undervaluation.",
      "url": "https://finnhub.io/api/news?id=ed68f4a9a8b1fc6054e82029468c3ffe75e2075c44a02f5a1258d00dc3214a7c"
    }
  },
  {
    "ts": null,
    "headline": "2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 13.2%. This performance was significantly worse than the S&P 500’s 2.4% decline.",
    "url": "https://finnhub.io/api/news?id=228b29ee88fae9dd9999e859bff822bc44fc99363d925b40c0150db25e9fd011",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748838948,
      "headline": "2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down",
      "id": 134937445,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 13.2%. This performance was significantly worse than the S&P 500’s 2.4% decline.",
      "url": "https://finnhub.io/api/news?id=228b29ee88fae9dd9999e859bff822bc44fc99363d925b40c0150db25e9fd011"
    }
  }
]